Skip to main content

Advertisement

Table 3 Total morbidity and complication rates

From: Implementation of goal-directed fluid therapy during hip revision arthroplasty: a matched cohort study

  Control group (n = 130) GDFT group (n = 130) p
Total morbidity 87 [66.9%] 64 [49.2%] 0.006
Infectious complications 13 [10%] 10 [7.7%] 0.663
Cardiac complications 10 [7.7%] 2 [1.5%] 0.034
Postoperative arrhythmia 9 [6.9%] 1 [0.8%] 0.019
Neurological complications 6 [4.6%] 7 [5.4%] 1.000
Renal complications 2 [1.5%] 2 [1.5%] 1.000
Hemorrhagic complications 80 [61.5%] 56 [43.1%] 0.004